MOB015B

MOB015B · Moberg Pharma AB

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for MOB015B, covering 2014-09-22 to 2024-06-26. Get the full timeline:

Most recent: Clinical Trial Update: A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO) [Phase 3]